InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: Saltz post# 40019

Friday, 04/19/2019 10:58:30 AM

Friday, April 19, 2019 10:58:30 AM

Post# of 232157
I am saying that GILD has not shown interest till now and not for combo. Mono may be different story but we are looking 2 more years

TNBC is more attractive - JNJ-PFE-LLY have breast cancer cdk-4/6 drug and they are fighting for dominance. If pro-140 shows delay or restrict the spread of cancer, these these 3 BP will be more interested and aggressive - so have TNBC 15 patient trial done and that can turn the table in 2019 - if only HIV, they can linger here till 2021
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News